<!DOCTYPE html>
<html>
 <head>
  <meta charset="utf-8"/>
  <meta content="width=device-width" initial-scale="1" name="viewport"/>
  <style>
   /* Create a running element */
        #header-and-footer {
          position: running(header-and-footer);
          text-align: right;
        }

        /* Add that running element to the top and bottom of every page */
        @page {
          @top {
            content: element(header-and-footer);
          }
          @bottom {
            content: element(header-and-footer);
          }
        }

        /* Add a page number */
        #page-number {
          content: "Page " counter(page);
        }

        /* Create a title page with a full-bleed background and no header */
        #title-page {
          page: title-page;
        }

        @page title-page {
          @top {
            content: "";
          }
        }

        #title-page h1 {
          padding: 200px 0 40px 0;
          font-size: 30px;
        }

        /* Dynamically create a table of contents with leaders */
        #table-of-contents a {
          content: target-content(attr(href)) leader('.') target-counter(attr(href), page);
          color: #000000;
          text-decoration: none;
          display: block;
          padding-top: 5px;
        }

        /* Float the footnote to a footnotes area on the page */
        .footnote {
          float: footnote;
          font-size: small;
        }

        .page {
          page-break-after: always;
        }

        body {
          counter-reset: chapter;
          font-family: 'Times New Roman';
          color: #000000;
        }
  </style>
  <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@400;600;800&amp;display=swap" rel="stylesheet"/>
  <link crossorigin="anonymous" href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.2/dist/css/bootstrap.min.css" integrity="sha384-T3c6CoIi6uLrA9TneNEoa7RxnatzjcDSCmG1MXxSR1GAsXEV/Dwwykc2MPK8M2HN" rel="stylesheet"/>
 </head>
 <body>
  <div class="page" id="title-page">
   <h1>
    Something Brief
   </h1>
   <div id="header-and-footer">
    <span id="page-number">
    </span>
   </div>
  </div>
  <div class="page" id="toc-page">
   <div id="table-of-contents">
    <a href="#section-0">
    </a>
    <a href="#section-1">
    </a>
    <a href="#section-2">
    </a>
    <a href="#section-3">
    </a>
    <a href="#section-4">
    </a>
    <a href="#section-5">
    </a>
    <a href="#section-6">
    </a>
    <a href="#section-7">
    </a>
    <a href="#section-8">
    </a>
    <a href="#section-9">
    </a>
    <a href="#section-10">
    </a>
    <a href="#section-11">
    </a>
    <a href="#section-12">
    </a>
    <a href="#section-13">
    </a>
    <a href="#section-14">
    </a>
    <a href="#section-15">
    </a>
   </div>
   <div id="header-and-footer">
    <span id="page-number">
    </span>
   </div>
  </div>
  <div class="page">
   <div>
    <table>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Sponsor Confidentiality Statement:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Full Title:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        Something Very Official
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Trial Acronym:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        SIMPLE
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Protocol Identifier:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        AP1234
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Original Protocol:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Version Number:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        1
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Version Date:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        2023-01-01
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Amendment Identifier:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        4
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Amendment Scope:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        Global
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Compound Codes(s):
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Compound Name(s):
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Trial Phase:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        Phase III Trial
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Short Title:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        Something Brief
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Sponsor Name and Address:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        ACME Pharma, Somewhere, In a City, In a District, In a big state, 12345, France
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Regulatory Agency Identifier Number(s):
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        NCT12345678, EU12345, IND12345, WHO12345
       </p>
      </td>
     </tr>
     <tr>
      <th style="vertical-align: top; text-align: left">
       <p>
        Spondor Approval Date:
       </p>
      </th>
      <td style="vertical-align: top; text-align: left">
       <p>
        2022-12-16
       </p>
      </td>
     </tr>
    </table>
   </div>
  </div>
  <div class="page">
   <h1 id="section-1">
    1&amp;nbspPROTOCOL SUMMARY
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-1.1">
     1.1&amp;nbspProtocol Synopsis
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-1.2">
     1.2&amp;nbspTrial Schema
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-1.3">
     1.3&amp;nbspSchedule of Activities
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-2">
    2&amp;nbspINTRODUCTION
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-2.1">
     2.1&amp;nbspPurpose of Trial
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-2.2">
     2.2&amp;nbspSummary of Benefits and Risks
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-3">
    3&amp;nbspTRIAL OBJECTIVES, ENDPOINTS AND ESTIMANDS
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-3.1">
     3.1&amp;nbspPrimary Objectives
    </h2>
    <div>
     <table>
      <tr>
       <td style="vertical-align: top; text-align: left">
        <p>
         The primary efficacy objective for this study is to evaluate the efficacy of TCZ compared with placebo in combination with SOC for the treatment of severe COVID-19 pneumonia
        </p>
       </td>
       <td style="vertical-align: top; text-align: left">
        <p>
         Clinical status assessed using a 7-category ordinal scale at Day 28
        </p>
       </td>
      </tr>
      <tr>
       <td style="vertical-align: top; text-align: left">
        <p>
         The secondary efficacy objective for this study is to evaluate the efficacy of TCZ compared with placebo in combination with SOC for the treatment of severe COVID-19 pneumonia over the age of None
        </p>
       </td>
       <td style="vertical-align: top; text-align: left">
        <p>
         Time to clinical improvement (TTCI) defined as a National Early Warning Score 2 (NEWS2) of &lt;=2 maintained for 24 hours
        </p>
        <p>
         Time to improvement of at least 2 categories relative to baseline on a 7-category ordinal scale of clinical status
        </p>
       </td>
      </tr>
     </table>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-4">
    4&amp;nbspTRIAL DESIGN
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-4.1">
     4.1&amp;nbspDescription of Trial Design
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-4.1.1">
      4.1.1&amp;nbspParticipant Input into Design
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-4.2">
     4.2&amp;nbspRationale for Trial Design
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-4.2.1">
      4.2.1&amp;nbspRationale for Comparator
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-4.2.2">
      4.2.2&amp;nbspRationale for Adaptive or Novel Trial Design
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-4.2.3">
      4.2.3&amp;nbspOther Trial Design Considerations
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-4.3">
     4.3&amp;nbspAccess to Trial Intervention After End of Trial
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-4.4">
     4.4&amp;nbspStart of Trial and End of Trial
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-5">
    5&amp;nbspTRIAL POPULATION
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-5.1">
     5.1&amp;nbspSelection of Trial Population
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-5.2">
     5.2&amp;nbspRationale for Trial Population
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-5.3">
     5.3&amp;nbspInclusion Criteria
    </h2>
    <div>
     <p>
      Patients may be included in the study only if they meet
      <strong>
       all
      </strong>
      the following criteria:
     </p>
     <table>
      <tr>
       <td style="vertical-align: top; text-align: left">
        <p>
         1
        </p>
       </td>
       <td style="vertical-align: top; text-align: left">
        <p>
         Subjects shall be between None and None
        </p>
       </td>
      </tr>
      <tr>
       <td style="vertical-align: top; text-align: left">
        <p>
         2
        </p>
       </td>
       <td style="vertical-align: top; text-align: left">
        <p>
         Subjects shall be between None and [max_agexxx]
        </p>
       </td>
      </tr>
     </table>
    </div>
   </div>
   <div class="">
    <h2 id="section-5.4">
     5.4&amp;nbspExclusion Criteria
    </h2>
    <div>
     <p>
      Patients may be excluded in the study for
      <strong>
       any
      </strong>
      of the following reasons:
     </p>
     <table>
      <tr>
       <td style="vertical-align: top; text-align: left">
        <p>
         1
        </p>
       </td>
       <td style="vertical-align: top; text-align: left">
        <p>
         Subjects has been treated with Drug A at any time in the past
        </p>
       </td>
      </tr>
      <tr>
       <td style="vertical-align: top; text-align: left">
        <p>
         2
        </p>
       </td>
       <td style="vertical-align: top; text-align: left">
        <p>
         Pick up activity Demographics
        </p>
       </td>
      </tr>
     </table>
    </div>
   </div>
   <div class="">
    <h2 id="section-5.5">
     5.5&amp;nbspLifestyle Considerations
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-5.5.1">
      5.5.1&amp;nbspMeals and Dietary Restrictions
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-5.5.2">
      5.5.2&amp;nbspCaffeine, Alcohol, Tobacco, and Other Habits
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-5.5.3">
      5.5.3&amp;nbspPhysical Activity
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-5.5.4">
      5.5.4&amp;nbspOther Activity
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-5.6">
     5.6&amp;nbspScreen Failures
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-6">
    6&amp;nbspTRIAL INTERVENTION AND CONCOMITANT THERAPY
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-6.1">
     6.1&amp;nbspDescription of Trial Intervention
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.2">
     6.2&amp;nbspRationale for Trial Intervention
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.3">
     6.3&amp;nbspDosing and Administration
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-6.3.1">
      6.3.1&amp;nbspTrial Intervention Dose Modification
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.4">
     6.4&amp;nbspTreatment of Overdose
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.5">
     6.5&amp;nbspPreparation, Handling, Storage and Accountability
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-6.5.1">
      6.5.1&amp;nbspPreparation of Trial Intervention
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.5.2">
      6.5.2&amp;nbspHandling and Storage of Trial Intervention
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.5.3">
      6.5.3&amp;nbspAccountability of Trial Intervention
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.6">
     6.6&amp;nbspParticipant Assignment, Randomisation and Blinding
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-6.6.1">
      6.6.1&amp;nbspParticipant Assignment
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.6.2">
      6.6.2&amp;nbspRandomisation
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.6.3">
      6.6.3&amp;nbspBlinding and Unblinding
     </h3>
     <div>
      <p>
       Blinding and unblinding text here please
      </p>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.7">
     6.7&amp;nbspTrial Intervention Compliance
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-6.8">
     6.8&amp;nbspConcomitant Therapy
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-6.8.1">
      6.8.1&amp;nbspProhibited Concomitant Therapy
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.8.2">
      6.8.2&amp;nbspPermitted Concomitant Therapy
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.8.3">
      6.8.3&amp;nbspRescue Therapy
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-6.8.4">
      6.8.4&amp;nbspOther Therapy
     </h3>
     <div>
     </div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-7">
    7&amp;nbspDISCONTINUATION OF TRIAL INTERVENTION AND PARTICIPANT WITHDRAWAL FROM TRIAL
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-7.1">
     7.1&amp;nbspDiscontinuation of Trial Intervention
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-7.1.1">
      7.1.1&amp;nbspCriteria for Permanent Discontinuation of Trial Intervention
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-7.1.2">
      7.1.2&amp;nbspTemporary Discontinuation or Interruption of Trial Intervention
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-7.1.3">
      7.1.3&amp;nbspRechallenge
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-7.2">
     7.2&amp;nbspParticipant Withdrawal from the Trial
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-7.3">
     7.3&amp;nbspLost to Follow-Up
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-7.4">
     7.4&amp;nbspTrial Stopping Rules
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-8">
    8&amp;nbspTRIAL ASSESSMENTS AND PROCEDURES
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-8.1">
     8.1&amp;nbspScreening/Baseline Assessments and Procedures
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.2">
     8.2&amp;nbspEfficacy Assessments and Procedures
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.3">
     8.3&amp;nbspSafety Assessments and Procedures
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-8.3.1">
      8.3.1&amp;nbspPhysical Examination
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.3.2">
      8.3.2&amp;nbspVital Signs
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.3.3">
      8.3.3&amp;nbspElectrocardiograms
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.3.4">
      8.3.4&amp;nbspClinical Laboratory Assessments
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.3.5">
      8.3.5&amp;nbspSuicidal Ideation and Behaviour Risk Monitoring
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.4">
     8.4&amp;nbspAdverse Events and Serious Adverse Events
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-8.4.1">
      8.4.1&amp;nbspDefinitions of AE and SAE
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.2">
      8.4.2&amp;nbspTime Period and Frequency for Collecting AE and SAE Information
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.3">
      8.4.3&amp;nbspIdentifying AEs and SAEs
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.4">
      8.4.4&amp;nbspRecording of AEs and SAEs
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.5">
      8.4.5&amp;nbspFollow-up of AEs and SAEs
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.6">
      8.4.6&amp;nbspReporting of SAEs
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.7">
      8.4.7&amp;nbspRegulatory Reporting Requirements for SAEs
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.8">
      8.4.8&amp;nbspSerious and Unexpected Adverse Reaction Reporting
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.9">
      8.4.9&amp;nbspAdverse Events of Special Interest
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.4.10">
      8.4.10&amp;nbspDisease-related Events or Outcomes Not Qualifying as AEs or SAEs
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.5">
     8.5&amp;nbspPregnancy and Postpartum Information
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-8.5.1">
      8.5.1&amp;nbspParticipants Who Become Pregnant During the Trial
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.5.2">
      8.5.2&amp;nbspParticipants Whose Partners Become Pregnant
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.6">
     8.6&amp;nbspMedical Device Product Complaints for Drug/Device Combination Products
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-8.6.1">
      8.6.1&amp;nbspDefinition of Medical Device Product Complaints
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.6.2">
      8.6.2&amp;nbspRecording of Medical Device Product Complaints
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.6.3">
      8.6.3&amp;nbspTime Period and Frequency for Collecting Medical Device Product Complaints .
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.6.4">
      8.6.4&amp;nbspFollow-Up of Medical Device Product Complaints
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-8.6.5">
      8.6.5&amp;nbspRegulatory Reporting Requirements for Medical Device Product Complaints
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.7">
     8.7&amp;nbspPharmacokinetics
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.8">
     8.8&amp;nbspGenetics
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.9">
     8.9&amp;nbspBiomarkers
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-8.1">
     8.1&amp;nbspImmunogenicity Assessments
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-8.1.1">
      8.1.1&amp;nbspMedical Resource Utilisation and Health Economics
     </h3>
     <div>
     </div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-9">
    9&amp;nbspSTATISTICAL CONSIDERATIONS
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-9.1">
     9.1&amp;nbspAnalysis Sets
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.2">
     9.2&amp;nbspAnalyses Supporting Primary Objective(s)
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-9.2.1">
      9.2.1&amp;nbspStatistical Model, Hypothesis, and Method of Analysis
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-9.2.2">
      9.2.2&amp;nbspHandling of Intercurrent Events of Primary Estimand(s)
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-9.2.3">
      9.2.3&amp;nbspHandling of Missing Data
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-9.2.4">
      9.2.4&amp;nbspSensitivity Analysis
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-9.2.5">
      9.2.5&amp;nbspSupplementary Analysis
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.3">
     9.3&amp;nbspAnalysis Supporting Secondary Objective(s)
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.4">
     9.4&amp;nbspAnalysis of Exploratory Objective(s)
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.5">
     9.5&amp;nbspSafety Analyses
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.6">
     9.6&amp;nbspOther Analyses
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.7">
     9.7&amp;nbspInterim Analyses
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.8">
     9.8&amp;nbspSample Size Determination
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-9.9">
     9.9&amp;nbspProtocol Deviations
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-10">
    10&amp;nbspGENERAL CONSIDERATIONS: REGULATORY, ETHICAL, AND TRIAL OVERSIGHT
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-10.1">
     10.1&amp;nbspRegulatory and Ethical Considerations
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-10.2">
     10.2&amp;nbspCommittees
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-10.3">
     10.3&amp;nbspInformed Consent Process
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-10.4">
     10.4&amp;nbspData Protection
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-10.5">
     10.5&amp;nbspEarly Site Closure or Trial Termination
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-11">
    11&amp;nbspGENERAL CONSIDERATIONS: RISK MANAGEMENT AND QUALITY ASSURANCE
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-11.1">
     11.1&amp;nbspQuality Tolerance Limits
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-11.2">
     11.2&amp;nbspData Quality Assurance
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-11.3">
     11.3&amp;nbspSource Data
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-12">
    12&amp;nbspAPPENDIX: ADVERSE EVENTS AND SERIOUS ADVERSE EVENTS - DEFINITIONS, SEVERITY, AND CAUSALITY
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-12.1">
     12.1&amp;nbspFurther Details and Clarifications on the AE Definition
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-12.2">
     12.2&amp;nbspFurther Details and Clarifications on the SAE Definition
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-12.3">
     12.3&amp;nbspSeverity
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-12.4">
     12.4&amp;nbspCausality
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-13">
    13&amp;nbspAPPENDIX: DEFINITIONS AND SUPPORTING OPERATIONAL DETAILS
   </h1>
   <div>
   </div>
   <div class="">
    <h2 id="section-13.1">
     13.1&amp;nbspContraception and Pregnancy Testing
    </h2>
    <div>
    </div>
    <div class="">
     <h3 id="section-13.1.1">
      13.1.1&amp;nbspDefinitions Related to Childbearing Potential
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-13.1.2">
      13.1.2&amp;nbspContraception
     </h3>
     <div>
     </div>
    </div>
    <div class="">
     <h3 id="section-13.1.3">
      13.1.3&amp;nbspPregnancy Testing
     </h3>
     <div>
     </div>
    </div>
   </div>
   <div class="">
    <h2 id="section-13.2">
     13.2&amp;nbspClinical Laboratory Tests
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-13.3">
     13.3&amp;nbspCountry/Region-Specific Differences
    </h2>
    <div>
    </div>
   </div>
   <div class="">
    <h2 id="section-13.4">
     13.4&amp;nbspPrior Protocol Amendments
    </h2>
    <div>
    </div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-14">
    14&amp;nbspAPPENDIX: GLOSSARY OF TERMS
   </h1>
   <div>
   </div>
  </div>
  <div class="page">
   <h1 id="section-15">
    15&amp;nbspAPPENDIX: REFERENCES
   </h1>
   <div>
   </div>
  </div>
 </body>
</html>
